nir-vana innovation network

An Irish innovation-based biotechnology company, providing germ free eggs seeking a distribution contract to supply companies who manufacture vaccines in the pharmaceutical industry The company has developed a process of producing the world’s first germ free chicken eggs in commercial quantities for use primarily in the pharmaceutical industry and in cutting edge research. The disruptive technology will set a new “gold standard in the market” eliminating bacterial contamination and potential for increased viral yield in egg-based vaccine manufacturing. Supporting the manufacturing of vaccines and scientific research the product is available this year. Germ-Free eggs provide the industry with a superior product as currently 10-20% of eggs produced from normal or specific pathogen free (SPF) laying flocks are infected with bacteria and viruses on the inside causing delays to market and costing the industry millions of dollars each year. Germ-Free eggs provide many advantages over current sources of eggs. The company can also offer large scale production of recombinant proteins to good manufacturing practice standard using an avian transgenic platform compliant with USDA memo 800.65, NACE code 2120 manufacture of pharmaceutical preparations and European pharmacopoeia requirements. Applications of germ-free eggs/cells/tissues 1. Conventional (prophylactic) vaccines 2. Therapeutic vaccines 3. Pharmaceutical (e.g hyaluronic acid, phospholipids) The company has received patent protection in both Europe and the US for the process by which it produces germ free eggs. The company is a recipient of European Innovation Council funding in 2019 & 2022. The company is interested in finding opportunities to grow the business on world markets, and to provide distribution agreements to locate a distribution centre in a local market (either Europe, USA or Brazil) to help deliver a unique novel product. The company is interested in finding opportunities to grow the business on world markets, and to provide distribution agreements to provide germ free eggs to pharmaceutical companies producing vaccines.